HealthEquity director receives 1,263 RSU shares

HealthEquity, Inc. director Parker Stuart B. reported receiving 1,263 shares of common stock on February 2, 2026 at a price of $0 per share, reflecting the vesting of restricted stock units.

Rhea-AI Filing Summary

HealthEquity, Inc. director Parker Stuart B. reported receiving 1,263 shares of common stock on February 2, 2026 at a price of $0 per share, reflecting the vesting of restricted stock units. After this award, he directly holds 23,098 shares of HealthEquity common stock.

The footnote explains that each restricted stock unit equals one common share. Of this award, 316 shares vested on February 2, 2026, with an additional 316 shares each scheduled to vest on May 1 and August 1, 2026, and the remaining 315 shares vesting on November 1, 2026. Vested shares will be delivered to him upon the earlier of a change in control of HealthEquity, the end of his service, or his death.

Insider Trade Summary

Grant/Award: 1,263 shares

Grant/Award 1 txn

Insider Parker Stuart B.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,263	$0.00	$0.00

Holdings After Transaction: Common Stock — 23,098 shares (Direct)

Footnotes (1)

1. F1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 316 shares on February 2, 2026. The restricted stock units vest as to 316 shares each on May 1 and August 1 of 2026. The remaining 315 shares will vest on November 1, 2026. Vested shares will be delivered to the reporting person upon the earlier of a change of control of the issuer (as defined in the issuer's 2024 equity incentive plan), or the reporting person's termination of service (as defined in the issuer's 2024 equity incentive plan), or the reporting person's death.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HealthEquity (HQY) director Parker Stuart B. report?

HealthEquity director Parker Stuart B. reported acquiring 1,263 shares of common stock on February 2, 2026 at $0 per share. The shares came from vesting restricted stock units, increasing his directly held stake to 23,098 shares after the transaction.

How many HealthEquity (HQY) shares does Parker Stuart B. own after this Form 4 filing?

After the reported award, Parker Stuart B. directly owns 23,098 shares of HealthEquity common stock. This updated holding reflects the addition of 1,263 shares that were acquired through the vesting of restricted stock units on February 2, 2026 at no cash cost.

What is the vesting schedule for Parker Stuart B.’s restricted stock units at HealthEquity (HQY)?

The restricted stock units vest in stages: 316 shares vested on February 2, 2026, another 316 shares vest on May 1, 2026, 316 more vest on August 1, 2026, and the remaining 315 shares vest on November 1, 2026, all tied to continued service conditions.

At what price did HealthEquity (HQY) director Parker Stuart B. acquire the reported shares?

The Form 4 states that Parker Stuart B. acquired 1,263 shares of HealthEquity common stock at a price of $0 per share. These shares were issued upon vesting of restricted stock units, meaning there was no cash purchase involved for this particular transaction.

When will vested restricted stock units for HealthEquity (HQY) director Parker Stuart B. be delivered?

The filing explains that vested shares from the restricted stock units will be delivered to Parker Stuart B. upon the earlier of a change of control of HealthEquity, his termination of service with the company, or his death, as defined under the 2024 equity incentive plan.

What plan governs the restricted stock units reported by HealthEquity (HQY) director Parker Stuart B.?

The restricted stock units are granted under HealthEquity’s 2024 equity incentive plan. This plan defines key terms such as change of control and termination of service, and it governs when vested shares are ultimately delivered to the reporting director or his estate.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/04/2026 - 01:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Parker Stuart B.

(Last) (First) (Middle)

C/O HEALTHEQUITY, INC.

15 W. SCENIC POINTE DR., STE. 100

(Street)

DRAPER UT 84020

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/02/2026		A		1,263(1)	A	$0	23,098	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 316 shares on February 2, 2026. The restricted stock units vest as to 316 shares each on May 1 and August 1 of 2026. The remaining 315 shares will vest on November 1, 2026. Vested shares will be delivered to the reporting person upon the earlier of a change of control of the issuer (as defined in the issuer's 2024 equity incentive plan), or the reporting person's termination of service (as defined in the issuer's 2024 equity incentive plan), or the reporting person's death.

Remarks:

The Power of Attorney given by Mr. Parker was previously filed with the U.S. Securities and Exchange Commission on June 26, 2023 as an exhibit to a statement on Form 4 filed by Mr. Parker with respect to HealthEquity, Inc. and is hereby incorporated by reference.

	/s/ Michael Newton, Attorney-in-Fact	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.